drugset / Trial / NCT01228513
Efficacy and Safety of Different Concentrations of ZK245186 in Atopic Dermatitis (AD)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of three concentrations of a development drug compared to placebo in the treatment of atopic dermatitis.
Timeline
- Start
- 2010-11
- Primary completion
- 2011-07
- Completion
- 2012-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Mapracorat | Small molecule | 0.01 % | Topical |
| Comparator | Mapracorat | Small molecule | 0.03 % | Topical |
| Comparator | Mapracorat | Small molecule | 0.1 % | Topical |